Table 5.
Study | Type | Patients, n | Follow-up, wk | Treatment Arm | Control Arm | Outcomes measures |
---|---|---|---|---|---|---|
Itokazu27 | Prospective | 62 | 8 | Sodium hyaluronate 25 mg (1/wk × 5) | None | ROM; pain at rest, motion, pressure |
Calis11 | RCT | 95 | 12 | Sodium hyaluronate | Triamcinolone acetate vs PT vs no treatment | Pain severity with passive ROM, functional considerations |
Rovetta49 | RCT | 30 | 26 | Sodium hyaluronate + triamcinolone | Triamcinolone + PT | ROM, pain |
Tamai53 | Prospective | 11 | 6 | Sodium hyaluronate | None | Coefficient of enhancement of synovium on MRI, JOA score |
RCT, randomized controlled trial; ROM, range of motion; PT, physical therapy; MRI, magnetic resonance imaging; JOA, Japanese Orthopaedic Association shoulder score.